Observational Clinical Study of the Natural Course and Long-term Prognosis of Patients With Chronic Liver Disease

Launched by FIRST AFFILIATED HOSPITAL XI'AN JIAOTONG UNIVERSITY · Dec 9, 2022

Keywords

ClinConnect Summary

This clinical trial is studying the long-term effects and progression of chronic liver disease, which is a serious health issue affecting many people worldwide. Chronic liver disease can develop into more severe conditions like hepatitis, liver scarring, and even liver cancer if not diagnosed and treated early. The goal of this study is to gather information from patients over time to better understand how the disease behaves and how different factors can affect its progression.

To be eligible to participate, patients need to regularly visit a liver disease center and meet specific criteria, such as having chronic viral hepatitis, autoimmune liver disease, or non-alcoholic fatty liver disease. Unfortunately, patients recently diagnosed with liver cancer or those who have undergone a liver transplant cannot join. If you participate in this study, you can expect to provide information about your health and experiences, which will help researchers learn more about chronic liver disease and improve care for future patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Patients who regularly visit and follow up at the corresponding liver disease center
• 2. All patients meet at least one of the following diagnostic criteria for chronic liver disease:
• • Chronic viral hepatitis B
• • Chronic viral hepatitis C ③. Chronic viral hepatitis D ④. Autoimmune liver disease (PBC/AIH/PSC) ⑤. Non-alcoholic fatty liver disease ⑥. Alcoholic liver disease
• Exclusion Criteria:
• • 1. First visit diagnosed with hepatocellular carcinoma or after liver transplantation.
• • 2. Combined with other advanced malignant tumors.
• • 3. The patient refused to sign the informed consent form to participate in this study.

Trial Officials